Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free ARQT Stock Alerts $8.59 -0.29 (-3.27%) (As of 05/29/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$200,000.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$160,337.85 Get ARQT Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARQT Insider Buying and Selling by Quarter Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Arcutis Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/28/2024Masaru MatsudaInsiderSell1,775$9.01$15,992.75 5/17/2024Larry Todd EdwardsSVPSell7,640$8.98$68,607.20 3/4/2024Masaru MatsudaInsiderSell3,760$11.12$41,811.20 1/2/2024Patrick BurnettInsiderSell1,325$3.54$4,690.50 11/21/2023Masaru MatsudaInsiderSell1,850$1.98$3,663.00 10/24/2023Life Sciences Viii L FrazierMajor ShareholderBuy80,000$2.50$200,000.00 9/15/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$6.81$1,001 - $15,0008/21/2023Patrick BurnettInsiderSell1,605$7.04$11,299.20 5/31/2023Masaru MatsudaInsiderSell1,830$7.80$14,274.00 (Data available from 1/1/2013 forward) ARQT Insider Trading Activity - Frequently Asked Questions Who is on Arcutis Biotherapeutics's Insider Roster? The list of insiders at Arcutis Biotherapeutics includes Bhaskar Chaudhuri, David W Osborne, Howard G Welgus, Larry Todd Edwards, Life Sciences Viii L Frazier, Masaru Matsuda, Orbimed Advisors Llc, Patricia A Turney, Patrick Burnett, Scott L Burrows, and Todd Franklin Watanabe. Learn more on insiders at ARQT. What percentage of Arcutis Biotherapeutics stock is owned by insiders? 9.50% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings. Which Arcutis Biotherapeutics insiders have been buying company stock? The following insider purchased ARQT shares in the last 24 months: Life Sciences Viii L Frazier ($200,000.00). How much insider buying is happening at Arcutis Biotherapeutics? Insiders have purchased a total of 80,000 ARQT shares in the last 24 months for a total of $200,000.00 bought. Which Arcutis Biotherapeutics insiders have been selling company stock? The following insiders have sold ARQT shares in the last 24 months: David W Osborne ($55,825.77), Howard G Welgus ($950,270.00), Larry Todd Edwards ($68,607.20), Masaru Matsuda ($142,443.10), Orbimed Advisors Llc ($7,287,402.01), Patricia A Turney ($50,484.74), Patrick Burnett ($38,129.45), Scott L Burrows ($33,867.60), and Todd Franklin Watanabe ($610,522.17). How much insider selling is happening at Arcutis Biotherapeutics? Insiders have sold a total of 458,016 Arcutis Biotherapeutics shares in the last 24 months for a total of $9,237,552.04 sold. Which members of congress are trading Arcutis Biotherapeutics? Josh Gottheimer (D-NJ) has sold shares of Arcutis Biotherapeutics in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: Innoviva Insider Ownership Ocular Therapeutix Insider Ownership Kiniksa Pharmaceuticals Insider Ownership Phathom Pharmaceuticals Insider Ownership Supernus Pharmaceuticals Insider Ownership ORIC Pharmaceuticals Insider Ownership Nkarta Insider Ownership Karyopharm Therapeutics Insider Ownership BioXcel Therapeutics Insider Ownership Alkermes Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:ARQT) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWrite this ticker symbol down…StocksToTradeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWho are Nvidia’s New Silent Partners?Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.